PFAS have wide-ranging toxic effects. Now, researchers have found that two non-legacy PFAS, namely perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), appear to speed up biological aging in middle-aged men, ...
Feb 26, 2026
0
1
The largest ever study of non-meat diets and cancer risk has found that vegetarian diets are associated with lower risks of several cancers—breast, prostate, kidney and pancreatic cancers, and multiple myeloma—but a higher ...
Feb 26, 2026
0
0
Achondroplasia, also known as short-limb dwarfism, is associated with neurological symptoms and complications due to narrowing of the skeletal structures surrounding the spinal cord. Despite achondroplasia being the most ...
Feb 26, 2026
0
0
A monoclonal antibody created by the Nanobiotechnology for Diagnostics group (Nb4D) at the Institute of Advanced Chemistry of Catalonia (IQAC), part of the Spanish National Research Council (CSIC), has demonstrated in cell ...
Feb 26, 2026
0
0
Consumers can protect their skin from damaging ultraviolet (UV) light rays for as little as $40 a year—or as much as $1,400 a year—depending on how expensive a sunscreen they buy and how much of their skin they protect ...
Feb 26, 2026
0
0
In a new study published in Communications Biology, Houston Methodist researchers led by Sonia Villapol, Ph.D., found that short-term antibiotic treatment significantly reduced neuroinflammation and neurodegeneration following ...
Feb 26, 2026
0
0
An analysis of 35,000 Canadians shows that rising cannabis use and worsening mental-health symptoms are increasingly appearing together, with the connection between the two strengthening over time. The study, led by McMaster ...
Feb 26, 2026
0
0
One to two out of every 100 newborn babies are born with a Congenital Heart Defect (CHD), yet the exact cause remains unclear. Human geneticists at the University Medicine Oldenburg (Germany) have now presented a new method ...
Feb 26, 2026
0
1
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men with prostate cancer, especially ...
Feb 26, 2026
0
0
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...
Feb 26, 2026
0
0
